These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 30941129)

  • 21. MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction.
    Cisilotto J; do Amaral AE; Rosolen D; Rode MP; Silva AH; Winter E; da Silva TE; Fischer J; Matiollo C; Rateke ECM; Narciso-Schiavon JL; Schiavon LL; Creczynski-Pasa TB
    Sci Rep; 2020 Jan; 10(1):100. PubMed ID: 31919459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
    Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
    J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.
    Zanetto A; Pelizzaro F; Mion MM; Bucci M; Ferrarese A; Simioni P; Basso D; Burra P; Senzolo M
    United European Gastroenterol J; 2023 Nov; 11(9):815-824. PubMed ID: 37792602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
    Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
    Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
    Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R
    Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis.
    Clària J; Curto A; Moreau R; Colsch B; López-Vicario C; Lozano JJ; Aguilar F; Castelli FA; Fenaille F; Junot C; Zhang I; Vinaixa M; Yanes O; Caraceni P; Trebicka J; Fernández J; Angeli P; Jalan R; Arroyo V
    J Hepatol; 2021 Nov; 75(5):1116-1127. PubMed ID: 34245803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.
    Blasi A; Calvo A; Prado V; Reverter E; Reverter JC; Hernández-Tejero M; Aziz F; Amoros A; Cardenas A; Fernández J
    Hepatology; 2018 Dec; 68(6):2325-2337. PubMed ID: 29790188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.
    Mücke MM; Rumyantseva T; Mücke VT; Schwarzkopf K; Joshi S; Kempf VAJ; Welsch C; Zeuzem S; Lange CM
    Liver Int; 2018 Apr; 38(4):645-653. PubMed ID: 28853199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
    Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW
    Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute-on-chronic liver failure in cirrhosis.
    Arroyo V; Moreau R; Kamath PS; Jalan R; Ginès P; Nevens F; Fernández J; To U; García-Tsao G; Schnabl B
    Nat Rev Dis Primers; 2016 Jun; 2():16041. PubMed ID: 27277335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Cao Z; Liu Y; Cai M; Xu Y; Xiang X; Zhao G; Cai W; Wang H; Wang W; Xie Q
    Am J Gastroenterol; 2020 Dec; 115(12):2026-2035. PubMed ID: 32858565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
    Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
    Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
    Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
    Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study.
    Ferreira Cardoso M; Alexandrino G; Carvalho E Branco J; Anapaz V; Carvalho R; Horta D; Martins A
    Gastroenterol Hepatol; 2019 May; 42(5):296-303. PubMed ID: 30772084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria.
    Dong X; He J; Chen W; Su R; Xu Y; Sheng X; Li L; Cao H
    Sci Rep; 2020 May; 10(1):8577. PubMed ID: 32444697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF.
    Zaccherini G; Aguilar F; Caraceni P; Clària J; Lozano JJ; Fenaille F; Castelli F; Junot C; Curto A; Formentin C; Weiss E; Bernardi M; Jalan R; Angeli P; Moreau R; Arroyo V
    J Hepatol; 2021 May; 74(5):1117-1131. PubMed ID: 33276029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.